Myobloc / Neurobloc
Myobloc / Neurobloc is the main commercial botulinum toxin type B brand node in the encyclopedia. It matters because it gives the site a concrete product-level reference point for type B rather than treating that serotype as only an abstract comparison category.
Market-aware context
Section titled “Market-aware context”In current U.S. materials, MYOBLOC is presented through Solstice Neurosciences within the broader Supernus commercial portfolio. Neurobloc was the corresponding European brand name, but European Medicines Agency materials now describe that EU marketing authorization as withdrawn. For this encyclopedia, the pair is best treated as one cross-market type B reference page rather than as separate regional routes.
Clinical role
Section titled “Clinical role”This brand is most closely associated in the current site graph with cervical dystonia. It also matters as a practical comparison point when readers want to understand how type B differs from the larger botulinum toxin type A brand ecosystem.
How to interpret it
Section titled “How to interpret it”Myobloc / Neurobloc should not be read as a parallel aesthetic competitor to the major type A brands. Its main value in the knowledge graph is serotype comparison, selected therapeutic use, and interpretation of issues such as potency systems, tolerability, and immunogenicity. The unit interpretation page explains why that comparison cannot be read on the same scale as the major type A brands. The storage and handling page adds the presentation and workflow context that separates this type B product node from the usual type A reconstitution discussion. The safety and adverse-effect framing page is a useful companion when readers interpret tolerability and serotype-specific tradeoffs.